A new report titled "Health Claims and Doses of Fish Oil Supplements in the US" that was published in JAMA Cardiology suggests that most fish oil supplement labels make claims about health benefits without trial data to support their efficacy. CRN weighs in.
Targeted News Service provides Washington Bureau coverage, federal contract and contracting information for awards and for subcontracting opportunities, a congressional vote chart, federal and congressional press releases.
Two of the dietary supplement industry’s most vocal critics in Congress – Senators Dick Durbin (D-IL) and Richard Blumenthal (D-CT) – have written to the FDA to express concerns about proposed changes to the Office of Dietary Supplement Programs (ODSP).
A new paper in JAMA Cardiology that criticizes the use of structure/function claims on omega-3 dietary supplements is “fraught with inaccuracies and never should have made it through the peer review process”, says the Global Organization for EPA and DHA Omega-3s (GOED).